Resveratoral Protects Against Angiotensin II-Induced Cellular Hypertrophy through Inhibition of CYP1B1/Mid-Chain Hydroxyeicosatetraenoic Acid Mechanism

被引：0
|
作者：
Shoieb, Sherif M. [1 ]
El-Kadi, Ayman O. S. [1 ]
机构：
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada
来源：
FASEB JOURNAL | 2019年 / 33卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
817.3
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450s 1B1 and Arachidonic Acid Metabolites
    Alammari, Ahmad H.
    O'Croinin, Conor
    Davies, Neal M.
    El-Kadi, Ayman
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 389
  • [42] Angiotensin (1-7) Attenuates Angiotensin II-Induced Cardiac Hypertrophy via a Sirt3-Dependent Mechanism
    Guo, Lirong
    Zhong, Tiecheng
    O'Rourke, Stephen T.
    Sun, Chengwen
    FASEB JOURNAL, 2017, 31
  • [43] Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap 1 and activating Nrf2 pathway
    Han, Jibo
    Shi, Xiaowen
    Zheng, Zhanxiong
    Zhang, Bin
    Shi, Fengjie
    Jiang, Liqin
    Xu, Jianjiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3985 - 3997
  • [44] The Lack of Sphingosine Kinase 1 in Smooth Muscle Cells Protects Mice Against Angiotensin II-Induced Hypertension
    Jozefczuk, Ewelina
    Szczepaniak, Piotr
    Mikolajczyk, Tomasz
    Ki, Ryszard Nosals
    Urbanski, Karol
    Wojciechowska, Emilia
    Filip, Grzegorz
    Stefanska, Monika
    Blyszczuk, Przemyslaw
    Guzik, Tomasz
    Siedlinski, Mateusz
    CIRCULATION, 2024, 150
  • [45] FXYD1 Protects Against Redox-Dependent Endothelial Dysfunction and Angiotensin II-Induced Hypertension
    Bubb, Kristen J.
    Tang, Owen
    Hansen, Thomas
    Galougahi, Keyvan Karimi
    Figtree, Gemma A.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S137 - S137
  • [46] Thioredoxin 1 negatively regulates angiotensin II-Induced cardiac hypertrophy through upregulation of miR-98
    Yang, Yanfei
    Ago, Tetsuro
    Sayed, Danish
    Aludellatif, Maha
    Sadoshima, Junichi
    CIRCULATION, 2007, 116 (16) : 248 - 248
  • [47] Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression
    Abdulrahman, Nabeel
    Ibrahim, Meram
    Joseph, Jensa Mariam
    Elkoubatry, Hanan Mahmoud
    Al-Shamasi, Al-Anood
    Rayan, Menatallah
    Gadeau, Alain Pierre
    Ahmed, Rashid
    Eldassouki, Hussein
    Hasan, Anwarul
    Mraiche, Fatima
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (06) : 1865 - 1872
  • [48] Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression
    Nabeel Abdulrahman
    Meram Ibrahim
    Jensa Mariam Joseph
    Hanan Mahmoud Elkoubatry
    Al-Anood Al-Shamasi
    Menatallah Rayan
    Alain Pierre Gadeau
    Rashid Ahmed
    Hussein Eldassouki
    Anwarul Hasan
    Fatima Mraiche
    Molecular and Cellular Biochemistry, 2022, 477 : 1865 - 1872
  • [49] Prevention of Angiotensin II- Induced Aortic Aneurysm And Associated Pathogenesis By Inhibiting CYP1B1 Or Its Gene Disruption (ApoE-/-/Cyp1b1-/- Mice)
    Thirunavukkarasu, Shyamala
    Khan, Nayaab
    Jennings, Brett
    Malik, Kafait
    FASEB JOURNAL, 2015, 29
  • [50] Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism
    Guo, Lirong
    Yin, Ankang
    Zhang, Qi
    Zhong, Tiecheng
    O'Rourke, Stephen T.
    Sun, Chengwen
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (05): : H980 - H991
12345